Monitoring bortezomib therapy in multiple myeloma: screening of cyclin D1, D2, and D3 via reliable real-time polymerase chain reaction and association with clinico-pathological features and outcome.

Source:http://linkedlifedata.com/resource/pubmed/id/20578819

Download in:

View as

General Info

PMID
20578819